InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,956.36
(
-0.48%
)
US TECH 100
20,356.80
(
-0.65%
)
Dow Jones
43,781.32
(
-0.40%
)
Brent Oil
72.24
(
0.51%
)
Bitcoin
88,577.04
(
-2.19%
)
Post# of 253597
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 75
Posts 4754
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Member Level

Re: dav1234 post# 175394

Wednesday, 03/12/2014 7:58:09 AM

Wednesday, March 12, 2014 7:58:09 AM

Post# of 253597

GERN -60% pre market ..1.66 low so far.. with $100M February raise I think they are barely trading above cash..overdone?



If(!!) the data is nothing more than was previously reported (mildly elevated Alk Phos and conj bill after long chronic use) then yes, way overdone IMO. The problem is I don't trust the company. Anything meaningfully worse than the previously reported mild issues could kill MF indication - since in the spectrum of 'chronic' (like PV/ET) vs 'immanently fatal' (like AML) MF is a meaningfully closer to chronic.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up